Success Story: Thanks to Our Assistance, NIW Approval for a Biomedical Engineering Researcher Advancing Drug Delivery Systems
Client’s Testimonial:
"I had a great experience working with the team on my EB-2 NIW I-140 petition. From the beginning, they were professional, knowledgeable, and very organized throughout the entire process. They provided clear guidance on the required documents, answered my questions promptly, and made what could have been a stressful process much more manageable. I especially appreciated their attention to detail and the way they helped present my academic and research background and proposed endeavor clearly and effectively. Communication was consistent throughout the preparation and filing process, and I always felt well informed about the next steps.
I am very happy that my I-140 petition was approved and truly appreciate the work and support the team provided throughout my case. I would highly recommend them to researchers and professionals considering an EB-2 NIW petition.”
On September 9th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Assistant in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: Research Assistant
Country of Origin: Iran
State of Residence at the Time of Filing: Connecticut
Approval Notice Date: September 9th, 2026
Processing Time: 10 months, 2 days (Premium Processing Upgrade Requested)
Case Summary:
Biomedical and healthcare challenges are becoming increasingly complex as researchers work to improve how advanced treatments are developed, delivered, and applied. We represented the client in an I-140 National Interest Waiver (NIW) petition based on research in biomedical engineering and therapeutic innovation. After a premium processing upgrade was requested, the petition was approved.
Developing Advanced Drug Delivery Platforms for Biomedical Innovation
Holding an M.S. in biomedical engineering, the client is currently conducting research at a U.S.based academic medical research institution. The proposed endeavor focuses on developing advanced biomaterial-based drug delivery systems to support innovative platforms for administering biological agents and RNA treatments. Rather than presenting the work as a narrow laboratory project, the petition emphasized how the client’s research supports precision medicine, improved therapeutic delivery, tissue repair, and safer treatment approaches for patients.
Building an Objective Record of Excellence
To establish that the client was well positioned to continue this endeavor, the petition documented a strong record of scholarly achievement that included:
- 5 peer-reviewed journal articles, including 1 co-first-authored article
- 7 conference abstracts, including 4 first-authored abstracts
- 78 citations to the client’s published research
- 4 recommendation letters, including 2 independent advisory opinions
- Research support from the National Science Foundation (NSF), the National Institutes of Health (NIH), and the Department of Defense (DoD)
Rather than presenting these accomplishments as numerical milestones alone, the petition explained how they demonstrated increasing recognition within the field. Independent researchers had incorporated the client’s findings into later studies involving drug delivery systems, microneedle fabrication, biomaterials, nanodelivery technologies, tissue engineering, and patient-focused therapeutic strategies. Several publications also ranked among highly cited Pharmacology & Toxicology articles for their respective publication years, including 1 paper within the top 1% and 2 papers within the top 10%. This comparative evidence helped show that the client’s work had attracted meaningful attention at rates above typical citation patterns for similar research.
Demonstrating National Importance
North America Immigration Law Group structured the petition by connecting the client’s research accomplishments with a clearly defined future research agenda. We demonstrated that the proposed endeavor extends beyond individual research projects by supporting more effective drug delivery, advancing RNA-based therapeutic platforms, improving tissue repair strategies, and contributing to biomedical innovation that may benefit patients in the United States.
The recommendation letters further supported the petition by explaining the client’s expertise and the broader value of the client’s work in biomedical engineering. One expert noted:
“To conclude, [Client] is an innovator who has advanced biomaterial-based platforms for drug delivery and soft tissue engineering to strengthen the competitiveness of the United States’ biomedical engineering research platform and address the burdens on severe tissue injuries on patients and the national healthcare system”
Looking Ahead
The approval of this NIW petition recognizes the importance of advancing biomaterial-based delivery systems for modern therapeutic platforms. Through objective evidence of scholarly achievement, citation impact, funded research involvement, expert support, and a nationally significant proposed endeavor, we successfully demonstrated that the client’s continued work can contribute meaningfully to biomedical engineering, drug delivery systems, tissue repair, and advanced therapeutic technologies in the United States.